SFM
ABBV icon

Sphera Funds Management’s AbbVie ABBV Stock Holding History

Sphera Funds Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-225,000
Closed -$24.1M – 171
2020
Q4 		$24.1M Buy
225,000
+100,000
+80% +$9.61M 2.14% 12
2020
Q3 		$10.9M Buy
+125,000
New +$11.8M 1.08% 25

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sphera Funds Management's ABBV Position: Q2 2026 in Review

Sphera Funds Management held its AbbVie (ABBV) position steady in Q2 2026 at 30,256 shares worth $7.61M. The position accounts for 0.99% of the portfolio, ranked #33.

Sphera Funds Management first reported a position in ABBV in Q3 2014 and has held it in 31 quarters since. The position peaked at $72.1M in Q2 2020. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sphera Funds Management held 30,256 shares of AbbVie worth $7.61M as of Q2 2026.
  • Sphera Funds Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.99% of Sphera Funds Management's portfolio in Q2 2026, its #33 holding.
  • Sphera Funds Management first reported a position in AbbVie in Q3 2014 and has held it in 31 quarters since.
  • Sphera Funds Management's AbbVie position peaked at $72.1M in Q2 2020.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.